Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001870583 | SCV002129711 | benign | not provided | 2023-12-22 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001870583 | SCV002599626 | uncertain significance | not provided | 2022-05-06 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign in association with a COL11A1-related disorder to our knowledge; Not located in the triple helical region, where the majority of pathogenic missense variants occur (Acke et al., 2014; HGMD); This variant is associated with the following publications: (PMID: 25240749, 25268133) |
Ambry Genetics | RCV002551059 | SCV003558901 | uncertain significance | Inborn genetic diseases | 2022-08-17 | criteria provided, single submitter | clinical testing | The c.5119C>T (p.R1707W) alteration is located in exon 66 (coding exon 66) of the COL11A1 gene. This alteration results from a C to T substitution at nucleotide position 5119, causing the arginine (R) at amino acid position 1707 to be replaced by a tryptophan (W). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |